Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | 0.0 | 0.0 |
Min SIP Amount | ₹500 | ₹100 |
Expense Ratio | 1.79 | 2.26 |
NAV | ₹246.16 | ₹154.54 |
Fund Started | 07 Feb 2000 | 13 Oct 2005 |
Fund Size | ₹6119.62 Cr | ₹1433.05 Cr |
Exit Load | Exit load of 1% if redeemed within 1 year | Exit load of 1% if redeemed within 15 days. |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 33.20% | 22.04% |
3 Year | 25.64% | 18.28% |
5 Year | 27.24% | 21.41% |
1 Year
3 Year
5 Year
Equity | 93.79% | 95.27% |
Cash | 5.80% | 3.36% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
HDFC Bank Ltd. | 4.74% |
ICICI Bank Ltd. | 3.73% |
Bharti Airtel Ltd. | 3.70% |
Zomato Ltd. | 3.60% |
Mahindra & Mahindra Ltd. | 3.20% |
Info Edge (India) Ltd. | 3.02% |
PB Fintech Ltd. | 2.67% |
Aster DM Healthcare Ltd. | 2.58% |
Mphasis Ltd. | 2.47% |
Reliance Industries Ltd. | 2.45% |
Name | Assets |
---|---|
ICICI Bank Ltd. | 7.53% |
Axis Bank Ltd. | 7.51% |
Reliance Industries Ltd. | 6.13% |
HDFC Bank Ltd. | 5.03% |
Bharti Airtel Ltd. | 4.90% |
State Bank of India | 4.23% |
Bajaj Finserv Ltd. | 4.22% |
NTPC Ltd. | 4.01% |
Infosys Ltd. | 3.73% |
Sun Pharmaceutical Industries Ltd. | 3.44% |
Name | R Janakiraman | Sri Sharma |
Start Date | 01 Mar 2014 | 30 Apr 2021 |
Name
Start Date
Description | The scheme aims to generate capital appreciation by capitalising on the long-term growth opportunities in the India economy. The scheme will invest in a broad range of stocks without any limitation either qualitative or quantitative and across market capitalization. | The scheme seeks to generate capital appreciation and income distribution to unit holders by investing predominantly in equity/equity related securities of the companies belonging to Exports & Services industry. |
Launch Date | 07 Feb 2000 | 13 Oct 2005 |
Description
Launch Date